Caj Haglund

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Immunohistochemistry

Concepts & Ideas

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Satomaa Tero; Heiskanen Annamari; Leonardsson Iréne; Angström Jonas; Olonen Anne; Blomqvist Maria; Salovuori Noora; Haglund Caj; Teneberg Susann; Natunen Jari; Carpén Olli; Saarinen Juhani
Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Thiel Alexandra; Ganesan Aparna; Mrena Johanna; Junnila Siina; Nykänen Antti; Hemmes Annabrita; Tai Hsin-Hsiung; Monni Outi; Kokkola Arto; Haglund Caj; Petrova Tatiana V; Ristimäki Ari
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Khanna Anchit; Böckelman Camilla; Hemmes Annabrita; Junttila Melissa R; Wiksten Jan-Patrik; Lundin Mikael; Junnila Siina; Murphy Daniel J; Evan Gerard I; Haglund Caj; Westermarck Jukka; Ristimäki Ari
MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Caj Haglund (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Satomaa Tero; Heiskanen Annamari; Leonardsson Iréne; Angström Jonas; Olonen Anne; Blomqvist Maria; Salovuori Noora; Haglund Caj; Teneberg Susann; Natunen Jari; Carpén Olli; Saarinen Juhani
Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Cancer research 2009;69(14):5811-9.
2009: Thiel Alexandra; Ganesan Aparna; Mrena Johanna; Junnila Siina; Nykänen Antti; Hemmes Annabrita; Tai Hsin-Hsiung; Monni Outi; Kokkola Arto; Haglund Caj; Petrova Tatiana V; Ristimäki Ari
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4572-80.
2009: Khanna Anchit; Böckelman Camilla; Hemmes Annabrita; Junttila Melissa R; Wiksten Jan-Patrik; Lundin Mikael; Junnila Siina; Murphy Daniel J; Evan Gerard I; Haglund Caj; Westermarck Jukka; Ristimäki Ari
MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.
Journal of the National Cancer Institute 2009;101(11):793-805.
2009: Linder Nina; Martelin Eeva; Lundin Mikael; Louhimo Johanna; Nordling Stig; Haglund Caj; Lundin Johan
Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.
European journal of cancer (Oxford, England : 1990) 2009;45(4):648-55.
2009: Hotakainen Kristina; Tanner Pirjo; Alfthan Henrik; Haglund Caj; Stenman Ulf-Håkan
Comparison of three immunoassays for CA 19-9.
Clinica chimica acta; international journal of clinical chemistry 2009;400(1-2):123-7.
2009: Kylänpää Leena; Hagström Jaana; Lepistö Anna; Linjama Tiina; Kärkkäinen Päivi; Kiviluoto Tuula; Haglund Caj
Syndecan-1 and tenascin expression in cystic tumors of the pancreas.
JOP : Journal of the pancreas 2009;10(4):378-82.
2008: Sturgeon Catharine M; Duffy Michael J; Stenman Ulf-Håkan; Lilja Hans; Brünner Nils; Chan Daniel W; Babaian Richard; Bast Robert C; Dowell Barry; Esteva Francisco J; Haglund Caj; Harbeck Nadia; Hayes Daniel F; Holten-Andersen Mads; Klee George G; Lamerz Rolf; Looijenga Leendert H; Molina Rafael; Nielsen Hans Jørgen; Rittenhouse Harry; Semjonow Axel; Shih Ie-Ming; Sibley Paul; Sölétormos György; Stephan Carsten; Sokoll Lori; Hoffman Barry R; Diamandis Eleftherios P;
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Clinical chemistry 2008;54(12):e11-79.
2008: Janér Joakim; Andersson Sture; Haglund Caj; Karikoski Riitta; Lassus Patrik
Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development.
Pediatrics 2008;122(2):340-6.
2008: Petrova Tatiana V; Nykänen Antti; Norrmén Camilla; Ivanov Konstantin I; Andersson Leif C; Haglund Caj; Puolakkainen Pauli; Wempe Frank; von Melchner Harald; Gradwohl Gérard; Vanharanta Sakari; Aaltonen Lauri A; Saharinen Juha; Gentile Massimiliano; Clarke Alan; Taipale Jussi; Oliver Guillermo; Alitalo Kari
Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.
Cancer cell 2008;13(5):407-19.
2008: Brosens Lodewijk A A; Keller Josbert J; Pohjola Leena; Haglund Caj; Morsink Folkert H; Iacobuzio-Donahue Christine; Goggins Michael; Giardiello Francis M; Ristimäki Ari; Offerhaus G Johan A
Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Cancer biology & therapy 2008;7(3):424-7.
2008: Koljonen Virve; Böhling Tom; Haglund Caj; Ristimäki Ari
Expression of HuR in Merkel cell carcinoma and in normal skin.
Journal of cutaneous pathology 2008;35(1):10-4.
2007: Heinonen Mira; Fagerholm Rainer; Aaltonen Kirsimari; Kilpivaara Outi; Aittomäki Kristiina; Blomqvist Carl; Heikkilä Päivi; Haglund Caj; Nevanlinna Heli; Ristimäki Ari
Prognostic role of HuR in hereditary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6959-63.
2007: Laukkarinen Johanna; Kiudelis Gediminas; Lempinen Marko; Räty Sari; Pelli Hanna; Sand Juhani; Kemppainen Esko; Haglund Caj; Nordback Isto
Increased prevalence of subclinical hypothyroidism in common bile duct stone patients.
The Journal of clinical endocrinology and metabolism 2007;92(11):4260-4.
2007: Kukko Heli; Koljonen Virve; Lassus Patrik; Tukiainen Erkki; Haglund Caj; Böhling Tom
Expression of vascular endothelial growth factor receptor-2 in Merkel cell carcinoma.
Anticancer research 2007;27(4C):2587-9.
2007: Kukko Heli; Koljonen Virve; Lassus Patrik; Tukiainen Erkki; Haglund Caj; Böhling Tom
Expression of endostatin in merkel cell carcinoma.
Anticancer research 2007;27(4C):2583-6.
2007: Janér Joakim; Andersson Sture; Haglund Caj; Lassus Patrik
Pulmonary endostatin perinatally and in lung injury of the newborn infant.
Pediatrics 2007;119(1):e241-6.
2007: Lundin M; Nordling S; Lundin J; Haglund C
Tenascin-C expression and its prognostic significance in colorectal cancer.
Oncology 2007;72(5-6):403-9.
2007: Railo Mikael; Lundin Johan; Haglund Caj; von Smitten Karl; Nordling Stig
Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(1):45-51.
2006: Koljonen V; Tukiainen E; Haglund C; Böhling T
Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma.
Histopathology 2006;49(5):551-3.
2006: Stenman Jakob; Paju Annukka; Rissanen Oso; Tenkanen Tuomas; Haglund Caj; Räsänen Jari; Salo Jarmo; Stenman Ulf-Håkan; Orpana Arto
Targeted gene-expression analysis by genome-controlled reverse transcription-PCR.
Clinical chemistry 2006;52(11):1988-96.
2006: Cederqvist Katariina; Janer Joakim; Tervahartiala Taina; Sorsa Timo; Haglund Caj; Salmenkivi Kaisa; Stenman Ulf-Håkan; Andersson Sture
Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat.
Pediatric research 2006;60(4):395-400.
2006: Mrena Johanna; Wiksten Jan-Patrik; Kokkola Arto; Nordling Stig; Haglund Caj; Ristimäki Ari
Prognostic significance of cyclin A in gastric cancer.
International journal of cancer. Journal international du cancer 2006;119(8):1897-901.
2006: Linder N; Haglund C; Lundin M; Nordling S; Ristimäki A; Kokkola A; Mrena J; Wiksten J-P; Lundin J
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.
Journal of clinical pathology 2006;59(9):965-71.
2006: Atula Timo; Hedström Johan; Ristimäki Ari; Finne Patrik; Leivo Ilmo; Markkanen-Leppänen Mari; Haglund Caj
Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.
Oncology reports 2006;16(3):485-90.
2006: Janér Joakim; Lassus Patrik; Haglund Caj; Paavonen Karri; Alitalo Kari; Andersson Sture
Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants.
American journal of respiratory and critical care medicine 2006;174(3):326-30.
2006: Lemeta Sebsebe; Salmenkivi Kaisa; Pylkkänen Lea; Sainio Markku; Saarikoski Sirkku T; Arola Johanna; Heikkilä Päivi; Haglund Caj; Husgafvel-Pursiainen Kirsti; Böhling Tom
Frequent loss of heterozygosity at 6q in pheochromocytoma.
Human pathology 2006;37(6):749-54.
2006: Mrena J; Wiksten J-P; Nordling S; Kokkola A; Ristimäki A; Haglund C
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
Journal of clinical pathology 2006;59(6):618-23.
2006: Siironen Päivi; Ristimäki Ari; Narko Kirsi; Nordling Stig; Louhimo Johanna; Andersson Sture; Haapiainen Reijo; Haglund Caj
VEGF-C and COX-2 expression in papillary thyroid cancer.
Endocrine-related cancer 2006;13(2):465-73.
2006: Koljonen Virve; Tukiainen Erkki; Haglund Caj; Böhling Tom
Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma.
Anticancer research 2006;26(3B):2209-12.
2006: Cederqvist Katariina; Sirén Vappu; Petäjä Jari; Vaheri Antti; Haglund Caj; Andersson Sture
High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Pediatrics 2006;117(4):1226-34.
2006: Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Journal of clinical pathology 2006;59(4):382-6.
2006: Thiel Alexandra; Heinonen Mira; Rintahaka Johanna; Hallikainen Tuija; Hemmes Annabrita; Dixon Dan A; Haglund Caj; Ristimäki Ari
Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.
The Journal of biological chemistry 2006;281(8):4564-9.
2006: Koljonen Virve; Böhling Tom; Tukiainen Erkki; Haglund Caj; Jahkola Tiina
Tenascin-C expression in Merkel cell carcinoma lymph node metastasis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2006;114(1):39-42.
2006: Hotakainen K; Bjartell A; Sankila A; Järvinen R; Paju A; Rintala E; Haglund C; Stenman U-H
Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer.
International journal of oncology 2006;28(1):95-101.
2006: Juuti Anne; Lundin Johan; Nordling Stig; Louhimo Johanna; Haglund Caj
Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
Oncology 2006;71(1-2):61-8.
2006: Stenman J; Räsänen J; Tenkanen T; Haglund C; Salo J; Orpana A; Paju A
Genome-controlled reverse transcriptase-polymerase chain reaction for targeted gene-expression analysis.
Scandinavian journal of clinical and laboratory investigation 2006;66(7):597-606.
2006: Lassus P; Janer J; Haglund C; Karikoski R; Andersson L C; Andersson S
Consistent expression of HGF and c-met in the perinatal lung.
Biology of the neonate 2006;90(1):28-33.
2005: Mrena Johanna; Wiksten Jan-Patrik; Thiel Alexandra; Kokkola Arto; Pohjola Leena; Lundin Johan; Nordling Stig; Ristimäki Ari; Haglund Caj
Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7362-8.
2005: Erkinheimo Tiina-Liisa; Sivula Anna; Lassus Heini; Heinonen Mira; Furneaux Henry; Haglund Caj; Butzow Ralf; Ristimäki Ari
Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
Gynecologic oncology 2005;99(1):14-9.
2005: Sivula Anna; Buskens Christianne J; van Rees Bastiaan P; Haglund Caj; Offerhaus G Johan A; van Lanschot J Jan B; Ristimäki Ari
Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.
International journal of cancer. Journal international du cancer 2005;116(6):903-8.
2005: Lassus Patrik; Ristimäki Ari; Huuhtanen Riikka; Tukiainen Erkki; Asko-Seljavaara Sirpa; Andersson Leif C; Miettinen Markku; Blomqvist Carl; Haglund Caj; Böhling Tom
Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation.
Anticancer research 2005;25(4):2669-74.
2005: Cederqvist Katariina; Haglund Caj; Heikkilä Päivi; Hollenberg Morley D; Karikoski Riitta; Andersson Sture
High expression of pulmonary proteinase-activated receptor 2 in acute and chronic lung injury in preterm infants.
Pediatric research 2005;57(6):831-6.
2005: Lauronen Jouni; Pakarinen Mikko P; Halttunen Jorma; Kuusanmäki Pekka; Haglund Caj; Paavonen Timo
Mucosal expression of p21, p27, p53, Bcl-2, and bax after small bowel resection and autotransplantation in pigs.
Pediatric surgery international 2005;21(5):351-5.
2005: Wiksten J-P; Lundin J; Nordling S; Kokkola A; Stenman U-H; Haglund C
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.
Histopathology 2005;46(4):380-8.
2005: Siironen Päivi; Louhimo Johanna; Nordling Stig; Ristimäki Ari; Mäenpää Hanna; Haapiainen Reijo; Haglund Caj
Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(2):57-64.
2005: Koljonen Virve; Haglund Caj; Tukiainen Erkki; Böhling Tom
Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.
Anticancer research 2005;25(2A):853-8.
2005: Heinonen Mira; Bono Petri; Narko Kirsi; Chang Sung-Hee; Lundin Johan; Joensuu Heikki; Furneaux Henry; Hla Timothy; Haglund Caj; Ristimäki Ari
Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
Cancer research 2005;65(6):2157-61.
2005: Koljonen V; Jahkola T; Tukiainen E; Granroth G; Haglund C; Böhling T
Tenascin-C in primary Merkel cell carcinoma.
Journal of clinical pathology 2005;58(3):297-300.
2005: Carpelan-Holmström M; Nordling S; Pukkala E; Sankila R; Lüttges J; Klöppel G; Haglund C
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.
Gut 2005;54(3):385-7.
2005: Sivula Anna; Talvensaari-Mattila Anne; Lundin Johan; Joensuu Heikki; Haglund Caj; Ristimäki Ari; Turpeenniemi-Hujanen Taina
Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.
Breast cancer research and treatment 2005;89(3):215-20.
2005: Kokkola Arto; Louhimo Johanna; Puolakkainen Pauli; Alfthan Henrik; Haglund Caj; Rautelin Hilpi
Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
World journal of gastroenterology : WJG 2005;11(7):1032-6.
2005: Siironen Paivi; Nordling Stig; Louhimo Johanna; Haapiainen Reijo; Haglund Caj
Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(1):50-6.
2005: Koljonen Virve; Lassus Patrik; Tukiainen Erkki; Ristimäki Ari; Haglund Caj; Böhling Tom
Cyclooxygenase-2 expression in primary Merkel cell carcinoma.
Journal of cutaneous pathology 2005;32(1):55-8.
2005: Lundin M; Nordling S; Lundin J; Isola J; Wiksten J-P; Haglund C
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer.
Oncology 2005;68(4-6):306-13.
2005: Juuti Anne; Nordling Stig; Lundin Johan; Louhimo Johanna; Haglund Caj
Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
Oncology 2005;68(2-3):97-106.
2004: Juuti A; Nordling S; Louhimo J; Lundin J; Haglund C
Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.
Journal of clinical pathology 2004;57(11):1151-5.
2004: Louhimo Johanna; Kokkola Arto; Alfthan Henrik; Stenman Ulf-Håkan; Haglund Caj
Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
International journal of cancer. Journal international du cancer 2004;111(6):929-33.
2004: Carpelan-Holmström Monika; Louhimo Johanna; Stenman Ulf-Håkan; Alfthan Henrik; Järvinen Heikki; Haglund Caj
CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(5-6):228-34.
2004: Salmenkivi Kaisa; Heikkilä Päivi; Haglund Caj; Arola Johanna
Malignancy in pheochromocytomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(9):551-9.
2004: Paju Annukka; Vartiainen Juhani; Haglund Caj; Itkonen Outi; von Boguslawski Kristina; Leminen Arto; Wahlström Torsten; Stenman Ulf-Håkan
Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4761-8.
2004: Räty Sari; Sand Juhani; Alfthan Henrik; Haglund Caj; Nordback Isto
Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2004;8(5):569-74.
2004: Siironen P; Ristimäki A; Nordling S; Louhimo J; Haapiainen R; Haglund C
Expression of COX-2 is increased with age in papillary thyroid cancer.
Histopathology 2004;44(5):490-7.
2004: Koljonen Virve; Tukiainen Erkki; Haglund Caj; Böhling Tom
Expression of cyclin A in Merkel cell carcinoma.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(1):39-44.
2004: Erkinheimo Tiina-Liisa; Lassus Heini; Finne Patrik; van Rees Bastiaan P; Leminen Arto; Ylikorkala Olavi; Haglund Caj; Butzow Ralf; Ristimäki Ari
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):538-45.
2004: Oberg Kjell; Astrup Lone; Eriksson Barbro; Falkmer Sture E; Falkmer Ursula G; Gustafsen Jens; Haglund Caj; Knigge Ulrich; Vatn Morten H; Välimäki Matti;
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.
Acta oncologica (Stockholm, Sweden) 2004;43(7):626-36.
2004: Oberg Kjell; Astrup Lone; Eriksson Barbro; Falkmer Sture E; Falkmer Ursula G; Gustafsen Jens; Haglund Caj; Knigge Ulrich; Vatn Morten H; Välimäki Matti;
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
Acta oncologica (Stockholm, Sweden) 2004;43(7):617-25.
2004: Leivonen Marja; Lundin Johan; Nordling Stig; von Boguslawski Kristina; Haglund Caj
Prognostic value of syndecan-1 expression in breast cancer.
Oncology 2004;67(1):11-8.
2004: Carpelan-Holmström Monika; Louhimo Johanna; Stenman Ulf-Håkan; Alfthan Henrik; Järvinen Heikki; Haglund Caj
Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
Oncology 2004;66(4):296-302.
2004: Louhimo Johanna; Alfthan Henrik; Stenman Ulf-Håkan; Haglund Caj
Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer.
Oncology 2004;66(2):126-31.
2003: Buskens C J; Sivula A; van Rees B P; Haglund C; Offerhaus G J A; van Lanschot J J B; Ristimäki A
Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.
Gut 2003;52(12):1678-83.
2003: Erkinheimo Tiina-Liisa; Lassus Heini; Sivula Anna; Sengupta Sibani; Furneaux Henry; Hla Timothy; Haglund Caj; Butzow Ralf; Ristimäki Ari
Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.
Cancer research 2003;63(22):7591-4.
2003: Saukkonen Kirsi; Rintahaka Johanna; Sivula Anna; Buskens Christianne J; Van Rees Bastiaan P; Rio Marie-Christine; Haglund Caj; Van Lanschot J Jan B; Offerhaus G Johan A; Ristimaki Ari
Cyclooxygenase-2 and gastric carcinogenesis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(10):915-25.
2003: Voutilainen Petri E; Siironen Päivi; Franssila Kaarle O; Sivula Arto; Haapiainen Reijo K; Haglund Caj H
AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Anticancer research 2003;23(5b):4283-8.
2003: Cederqvist Katariina; Haglund Caj; Heikkilä Päivi; Sorsa Timo; Tervahartiala Taina; Stenman Ulf-Håkan; Andersson Sture
Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants.
Pediatrics 2003;112(3 Pt 1):570-7.
2003: Salmenkivi K; Heikkilä P; Haglund C; Louhimo J; Arola J
Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas.
Histopathology 2003;43(1):62-71.
2003: Atula Timo; Hedström Johan; Finne Patrik; Leivo Ilmo; Markkanen-Leppänen Mari; Haglund Caj
Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Anticancer research 2003;23(3C):3051-6.
2003: Hotakainen Kristina; Ljungberg Börge; Haglund Caj; Nordling Stig; Paju Annukka; Stenman Ulf-Hakan
Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.
International journal of cancer. Journal international du cancer 2003;104(5):631-5.
2003: Salmenkivi Kaisa; Heikkilä Päivi; Liu Jianqi; Haglund Caj; Arola Johanna
VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(4):458-64.
2003: Juuti A; Nordling S; Louhimo J; Lundin J; von Boguslawski K; Haglund C
Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.
Oncology 2003;65(4):371-7.
2003: Wiksten Jan-Patrik; Lundin Johan; Nordling Stig; Lundin Mikael; Kokkola Arto; von Boguslawski Kristina; Haglund Caj
Tenascin-C expression correlates with prognosis in gastric cancer.
Oncology 2003;64(3):245-50.
2002: Louhimo Johanna; Carpelan-Holmström Monika; Alfthan Henrik; Stenman Ulf-Håkan; Järvinen Heikki J; Haglund Caj
Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
International journal of cancer. Journal international du cancer 2002;101(6):545-8.
2002: Carpelan-Holmström M; Louhimo J; Stenman U H; Alfthan H; Haglund C
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Anticancer research 2002;22(4):2311-6.
2002: Hotakainen Kristina; Haglund Caj; Paju Annukka; Nordling Stig; Alfthan Henrik; Rintala Erkki; Stenman Ulf-Håkan
Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
European urology 2002;41(6):677-85.
2002: Buskens Christianne J; Van Rees Bastiaan P; Sivula Anna; Reitsma Johannes B; Haglund Caj; Bosma Piter J; Offerhaus G Johan A; Van Lanschot J Jan B; Ristimäki Ari
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
Gastroenterology 2002;122(7):1800-7.
2002: Louhimo Johanna; Finne Patrik; Alfthan Henrik; Stenman Ulf-Håken; Haglund Caj
Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.
Anticancer research 2002;22(3):1759-64.
2002: Hemmer Samuli; Wasenius Veli Matti; Haglund Caj; Zhu Ying; Knuutila Sakari; Franssila Kaarle; Joensuu Heikki
Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas.
Cancer genetics and cytogenetics 2002;134(1):13-7.
2002: Ristimäki Ari; Sivula Anna; Lundin Johan; Lundin Mikael; Salminen Tiina; Haglund Caj; Joensuu Heikki; Isola Jorma
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Cancer research 2002;62(3):632-5.
2002: Wiksten Jan-Patrik; Lundin Johan; Nordling Stig; Kokkola Arto; von Boguslawski Kristina; Haglund Caj
The prognostic value of p27 in gastric cancer.
Oncology 2002;63(2):180-4.
2001: Salmenkivi K; Haglund C; Ristimäki A; Arola J; Heikkilä P
Increased expression of cyclooxygenase-2 in malignant pheochromocytomas.
The Journal of clinical endocrinology and metabolism 2001;86(11):5615-9.
2001: Salmenkivi K; Haglund C; Arola J; Heikkilä P
Increased expression of tenascin in pheochromocytomas correlates with malignancy.
The American journal of surgical pathology 2001;25(11):1419-23.
2001: Voutilainen P E; Multanen M M; Leppäniemi A K; Haglund C H; Haapiainen R K; Franssila K O
Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age.
Thyroid : official journal of the American Thyroid Association 2001;11(10):953-7.
2001: Leivonen M; Nordling S; Lundin J; von Boguslawski K; Haglund C
p27 expression correlates with short-term, but not with long-term prognosis in breast cancer.
Breast cancer research and treatment 2001;67(1):15-22.
2001: Louhimo J; Nordling S; Alfthan H; von Boguslawski K; Stenman U H; Haglund C
Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies.
Histopathology 2001;38(5):418-24.
2001: Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman U H
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
British journal of cancer 2001;84(10):1363-71.
2001: Salmenkivi K; Arola J; Voutilainen R; Ilvesmäki V; Haglund C; Kahri A I; Heikkilä P; Liu J
Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
The Journal of clinical endocrinology and metabolism 2001;86(5):2231-5.
2001: Hedström J; Haglund C; Leinonen J; Nordling S; Stenman U H
Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas.
Scandinavian journal of clinical and laboratory investigation 2001;61(2):111-8.
2001: Hemmer S; Wasenius V M; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
The American journal of pathology 2001;158(4):1355-62.
2001: Ristimäki A; Nieminen O; Saukkonen K; Hotakainen K; Nordling S; Haglund C
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
The American journal of pathology 2001;158(3):849-53.
2001: Lundin M; Nordling S; Lundin J; Alfthan H; Stenman U H; Haglund C
Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression.
International journal of cancer. Journal international du cancer 2001;95(1):18-22.
2001: Wiksten J P; Lundin J; Nordling S; Lundin M; Kokkola A; von Boguslawski K; Haglund C
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.
International journal of cancer. Journal international du cancer 2001;95(1):1-6.
2001: Leivonen M; Nordling S; Lundin J; von Boguslawski K; Haglund C
STn and prognosis in breast cancer.
Oncology 2001;61(4):299-305.
2000: Sirén J; Haglund C; Haapiainen R
An institutional experience with 40 first lateral transperitoneal laparoscopic adrenalectomies.
Surgical laparoscopy, endoscopy & percutaneous techniques 2000;10(6):382-6.
2000: Lundin M; Nordling S; Carpelan-Holmstrom M; Louhimo J; Alfthan H; Stenman U H; Haglund C
A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.
Anticancer research 2000;20(6D):4949-51.
2000: Wiksten J P; Lundin J; Nordling S; Kokkola A; Haglund C
A prognostic value of syndecan-1 in gastric cancer.
Anticancer research 2000;20(6D):4905-7.
2000: Voutilainen P E; Haglund C H
Ultrasonically activated shears in thyroidectomies: a randomized trial.
Annals of surgery 2000;231(3):322-8.
2000: Voutilainen P E; Multanen M; Haapiainen R K; Haglund C H; Sane T; Sivula A H
Long term prognosis of medullary thyroid carcinoma in 39 patients.
Annales chirurgiae et gynaecologiae 2000;89(4):292-7.
1999: Hedström J; Haglund C; Kemppainen E; Leinimaa M; Leinonen J; Stenman U H
Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancer.
Clinical chemistry 1999;45(10):1768-73.
1999: Hedström J; Grenman R; Ramsay H; Finne P; Lundin J; Haglund C; Alfthan H; Stenman U H
Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx.
International journal of cancer. Journal international du cancer 1999;84(5):525-8.
1999: Lundin M; Nordling S; Roberts P J; Lundin J; Carpelan-Holmström M; von Boguslawsky K; Haglund C
Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.
Oncology 1999;57(1):70-6.
1999: Sirén J; Haglund C; Huikuri K; Sivula A; Haapiainen R
Laparoscopic adrenalectomy for primary aldosteronism: clinical experience in 12 patients.
Surgical laparoscopy & endoscopy 1999;9(1):9-13.
1999: Victorzon M; Lundin M; Haglund C; Roberts P J; Kellokumpu I
Short and long term outcome after laparoscopic cholecystectomy.
Annales chirurgiae et gynaecologiae 1999;88(4):259-63.
1998: Jahkola T; Toivonen T; Virtanen I; von Smitten K; Nordling S; von Boguslawski K; Haglund C; Nevanlinna H; Blomqvist C
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
British journal of cancer 1998;78(11):1507-13.
1998: Voutilainen P E; Haapiainen R K; Haglund C H
Ultrasonically activated shears in thyroid surgery.
American journal of surgery 1998;175(6):491-3.
1998: Leivonen M; Nordling S; Haglund C
The course of Helicobacter pylori infection after partial gastrectomy for peptic ulcer disease.
Hepato-gastroenterology 1998;45(20):587-91.
1997: Leivonen M; Nordling S; Haglund C
Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types?
Anticancer research 1997;17(5B):3893-6.
1997: Victorzon M; Roberts P J; Haglund C; von Boguslawsky K; Nordling S
Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
Anticancer research 1997;17(4B):2923-6.
1997: Leivonen M K; Haglund C H; Nordling S F
Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease.
European journal of gastroenterology & hepatology 1997;9(4):371-4.
1997: Haglund C; Ylätupa S; Mertaniemi P; Partanen P
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.
British journal of cancer 1997;76(6):777-83.
1997: Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(4):369-74.
1996: Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman U H; Roberts P J
Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
British journal of cancer 1996;74(6):925-9.
1996: Victorzon M; Lundin J; Haglund C; Nordling S; Roberts P J
A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy--a multivariate analysis.
International journal of cancer. Journal international du cancer 1996;67(2):190-3.
1996: Carpelan-Holmström M A; Haglund C H; Roberts P J
Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
Diseases of the colon and rectum 1996;39(7):799-805.
1996: Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(7):1156-61.
1996: Victorzon M; Roberts P J; Haglund C; von Boguslawsky K; Nordling S
Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
Oncology 1996;53(3):182-91.
1996: Hedström J; Haglund C; Haapiainen R; Stenman U H
Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas.
International journal of cancer. Journal international du cancer 1996;66(3):326-31.
1996: Carpelan-Holmström M A; Haglund C H; Järvinen H J; Roberts P J
Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Anticancer research 1996;16(2):981-6.
1996: Lundin J; Nordling S; von Boguslawsky K; Roberts P J; Haglund C
Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.
Oncology 1996;53(2):104-11.
1996: Victorzon M; Nordling S; Haglund C; Lundin J; Roberts P J
Expression of p53 protein as a prognostic factor in patients with gastric cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):215-20.
1996: Victorzon M; Nordling S; Nilsson O; Roberts P J; Haglund C
Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.
International journal of cancer. Journal international du cancer 1996;65(3):295-300.
1995: Lundin J; Nordling S; von Boguslawsky K; Roberts P J; Haglund C
Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Anticancer research 1995;15(6B):2659-68.
1995: Lundin J; Roberts P J; Kuusela P; Haglund C
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9.
Anticancer research 1995;15(5B):2181-6.
1995: Victorzon M; Haglund C; Lundin J; Roberts P J
A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):379-84.
1995: Ylätupa S; Mertaniemi P; Haglund C; Partanen P
Enzyme immunoassay for quantification of tenascin in biologic samples.
Clinical biochemistry 1995;28(3):263-8.
1995: Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts P J
Preoperative serum levels of CEA and CA 242 in colorectal cancer.
British journal of cancer 1995;71(4):868-72.
1995: Ylätupa S; Haglund C; Mertaniemi P; Vahtera E; Partanen P
Cellular fibronectin in serum and plasma: a potential new tumour marker?
British journal of cancer 1995;71(3):578-82.
1995: Scheinin B; Kellokumpu I; Lindgren L; Haglund C; Rosenberg P H
Effect of intraperitoneal bupivacaine on pain after laparoscopic cholecystectomy.
Acta anaesthesiologica Scandinavica 1995;39(2):195-8.
1995: Ylätupa S; Mertaniemi P; Haglund C; Partanen P
An improved method for quantification of extra domain A-containing cellular fibronectin (EDAcFN) in different body fluids.
Clinica chimica acta; international journal of clinical chemistry 1995;234(1-2):79-90.
1994: Haglund C; Lundin J; Kuusela P; Roberts P J
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
British journal of cancer 1994;70(3):487-92.
1994: Lundin J; Roberts P J; Kuusela P; Haglund C
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.
British journal of cancer 1994;69(3):515-9.
1994: Halme L; Haglund C; Nordling S; Ahonen J
Large mesenteric mass caused by a mesenteric desmoid tumour.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1994;20(1):69-72.
1993: Ylätupa S; Partanen P; Haglund C; Virtanen I
Competitive enzyme immunoassay for quantification of the cellular form of fibronectin (EDAcFN) in blood samples.
Journal of immunological methods 1993;163(1):41-7.
1992: Alfthan H; Haglund C; Dabek J; Stenman U H
Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women.
Clinical chemistry 1992;38(10):1981-7.
1992: Alfthan H; Haglund C; Roberts P; Stenman U H
Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease.
Cancer research 1992;52(17):4628-33.
1992: Söderholm A L; Lindqvist C; Haglund C
Tumour markers and radiological examinations in the follow-up of patients with oral cancer.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 1992;20(5):211-5.
1992: Haglund C; Roberts P J; Jalanko H; Kuusela P
Tumour markers CA 19-9 and CA 50 in digestive tract malignancies.
Scandinavian journal of gastroenterology 1992;27(3):169-74.
1991: Haglund C; Kuusela P; Roberts P; Jalanko H
Tumour marker CA 125 in patients with digestive tract malignancies.
Scandinavian journal of clinical and laboratory investigation 1991;51(3):265-270.
1991: Kuusela P; Haglund C; Roberts P J
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
British journal of cancer 1991;63(4):636-40.
1991: Haglund C; Lindgren J; Roberts P J; Nordling S
Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
British journal of cancer 1991;63(3):386-9.
1989: Haglund C; Lindgren J; Roberts P J; Kuusela P; Nordling S
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
British journal of cancer 1989;60(6):845-51.
1989: Haglund C; Roberts P J; Nordling S
Expression of laminin in benign and malignant sclerosing lesions of extrahepatic bile ducts.
Journal of clinical pathology 1989;42(9):927-30.
1989: Haglund C; Kuusela P; Roberts P J
Tumour markers in pancreatic cancer.
Annales chirurgiae et gynaecologiae 1989;78(1):41-53.
1989: Roberts P J; Haglund C; Onali M; Kuusela P
Tumour markers in gastric cancer.
Annales chirurgiae et gynaecologiae 1989;78(1):38-40.
1987: Halila H; Huhtala M L; Haglund C; Nordling S; Stenman U H
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
British journal of cancer 1987;56(2):153-6.
1986: Haglund C; Lindgren J; Roberts P J; Nordling S
Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
International journal of cancer. Journal international du cancer 1986;38(6):841-6.
1986: Haglund C; Huhtala M L; Halila H; Nordling S; Roberts P J; Scheinin T M; Stenman U H
Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases.
British journal of cancer 1986;54(2):297-303.
1986: Haglund C; Lindgren J; Roberts P J; Nordling S
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
British journal of cancer 1986;53(2):189-95.
1986: Haglund C; Roberts P J; Kuusela P; Scheinin T M; Mäkelä O; Jalanko H
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
British journal of cancer 1986;53(2):197-202.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Caj Haglund

Research Profile (preview)

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Caj Haglund (preview)

All Publications